Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VVZ-149 Injection for Post-operative Pain Following Total Hip Arthroplasty
KCT0002653Phase 2Terminated
- Sponsor
- Vivozon
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of opiranserin in postoperative pain, sponsored by Vivozon. Started Dec 2017; status: terminated.
02
Drugs
opiranserin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on KCT0002653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002653.